☰

Daniela Gundisch - Publications

Affiliations: 
University of Bonn, Bonn, Nordrhein-Westfalen, Germany 
Area:
Organic Chemistry
Tree Info Similar researchers PubMed Report error

41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Tomassoli I, Gündisch D. Bispidine as a Privileged Scaffold. Current Topics in Medicinal Chemistry. PMID 26369817 DOI: 10.2174/1568026615666150915111434  0.383
2015 Tomassoli I, Gündisch D. The twin drug approach for novel nicotinic acetylcholine receptor ligands. Bioorganic & Medicinal Chemistry. 23: 4375-89. PMID 26142318 DOI: 10.1016/j.bmc.2015.06.034  0.507
2014 Zlotos DP, Tränkle C, Holzgrabe U, Gündisch D, Jensen AA. Semisynthetic analogues of toxiferine I and their pharmacological properties at α7 nAChRs, muscle-type nAChRs, and the allosteric binding site of muscarinic M2 receptors. Journal of Natural Products. 77: 2006-13. PMID 25192059 DOI: 10.1021/np500259j  0.441
2013 Eibl C, Tomassoli I, Munoz L, Stokes C, Papke RL, Gündisch D. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents. Bioorganic & Medicinal Chemistry. 21: 7283-308. PMID 24156938 DOI: 10.1016/j.bmc.2013.09.059  0.483
2013 Eibl C, Munoz L, Tomassoli I, Stokes C, Papke RL, Gündisch D. The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs. Bioorganic & Medicinal Chemistry. 21: 7309-29. PMID 24145137 DOI: 10.1016/j.bmc.2013.09.060  0.533
2012 Bucerius J, Manka C, Schmaljohann J, Mani V, Gündisch D, Rudd JH, Bippus R, Mottaghy FM, Wüllner U, Fayad ZA, Biersack HJ. Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo. Jacc. Cardiovascular Imaging. 5: 528-36. PMID 22595161 DOI: 10.1016/J.Jcmg.2011.11.024  0.416
2012 Bucerius J, Manka C, Schmaljohann J, Mani V, Gündisch D, Rudd J, Bippus R, Mottaghy F, Wüllner U, Fayad Z, Biersack H. In vivo PET-Bildgebung von vaskulären nikotinergen Acetylcholin-Rezeptoren mit [18F]-2-Fluoro-A85380 im Menschen Rofo-Fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren. 184. DOI: 10.1055/S-0031-1300902  0.349
2011 Gündisch D, Eibl C. Nicotinic acetylcholine receptor ligands, a patent review (2006-2011). Expert Opinion On Therapeutic Patents. 21: 1867-96. PMID 22098319 DOI: 10.1517/13543776.2011.637919  0.455
2011 Elsinghorst PW, Härtig W, Gündisch D, Mohr K, Tränkle C, Gütschow M. A hydrazide linker strategy for heterobivalent compounds as ortho- and allosteric ligands of acetylcholine-binding proteins. Current Topics in Medicinal Chemistry. 11: 2731-48. PMID 22039876 DOI: 10.2174/156802611798184427  0.491
2011 Tomassoli I, Eibl C, Wulf M, Papke R, Picciotto M, Gündisch D. The twin drug approach for novel nicotinic acetylcholine receptor (nAChR) ligands: Synthesis and structure–affinity relationships Biochemical Pharmacology. 82: 1028. DOI: 10.1016/J.BCP.2011.07.016  0.485
2007 Wüllner U, Wüllner U, Gündisch D, Herzog H, Minnerop M, Joe A, Warnecke M, Jessen F, Schütz C, Reinhardt M, Klockgether T, Schmaljohann J. Smoking upregulates α4β2∗ nicotinic acetylcholine receptors in brainstem and cerebellum Clinical Neurophysiology. 118: e111. DOI: 10.1016/j.clinph.2006.11.258  0.424
2006 Schmaljohann J, Gündisch D, Minnerop M, Bucerius J, Joe A, Reinhardt M, Guhlke S, Biersack HJ, Wüllner U. In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease. Nuclear Medicine and Biology. 33: 305-9. PMID 16631078 DOI: 10.1016/j.nucmedbio.2005.12.012  0.44
2006 Bucerius J, Joe AY, Schmaljohann J, Gündisch D, Minnerop M, Biersack HJ, Wüllner U, Reinhardt MJ. Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. 95: 105-9. PMID 16598519 DOI: 10.1007/s00392-006-0342-6  0.457
2006 Zlotos DP, Tränkle C, Abdelrahman A, Gündisch D, Radacki K, Braunschweig H, Mohr K. 6H,13H-Pyrazino[1,2-a;4,5-a']diindole analogs: probing the pharmacophore for allosteric ligands of muscarinic M2 receptors. Bioorganic & Medicinal Chemistry Letters. 16: 1481-5. PMID 16387499 DOI: 10.1016/J.Bmcl.2005.12.030  0.476
2006 Wüllner U, Gündisch D, Herzog H, Minnerop M, Joe A, Warnecke M, Jessen F, Schütz C, Reinhardt M, Eschner W, Klockgether T, Schmaljohann J. Smoking upregulates a4ß2* nicotinic acetylcholine receptors in brainstem and cerebellum Aktuelle Neurologie. 33. DOI: 10.1055/s-2006-953476  0.425
2006 Wüllner U, Bucerius J, Gündisch D, Minnerop M, Jessen F, Joe A, Klockgether T, Herzog H, Schmaljohann J. PET-Imaging of a4ß2* nicotinic acetylcholine receptors in the central and peripheral nervous system Aktuelle Neurologie. 33. DOI: 10.1055/S-2006-953461  0.466
2006 Wüllner U, Wüllner U, Gündisch D, Herzog H, Minnerop M, Joe A, Warnecke M, Jessen F, Schütz C, Reinhardt M, Klockgether T, Schmaljohann J. Smoking upregulates α4ß2* nicotinic acetylcholine receptors in brainstem and cerebellum Klinische Neurophysiologie. 37. DOI: 10.1055/s-2006-939320  0.339
2006 Bucerius J, Joe AY, Schmaljohann J, Gündisch D, Minnerop M, Biersack H, Wüllner U, Reinhardt MJ. Feasibility of 2–deoxy–2–[18F]fluoro–D–glucose– A85380–PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo Clinical Research in Cardiology. 95: 354-354. DOI: 10.1007/s00392-006-0397-4  0.384
2005 Schmaljohann J, Gündisch D, Minnerop M, Joe A, Bucerius J, Dittmar C, Jessen F, Guhlke S, Wüllner U. A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 63: 433-5. PMID 16024252 DOI: 10.1016/j.apradiso.2005.05.040  0.379
2005 Gündisch D, Koren AO, Horti AG, Pavlova OA, Kimes AS, Mukhin AG, London ED. In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors. Synapse (New York, N.Y.). 55: 89-97. PMID 15529332 DOI: 10.1002/syn.20096  0.553
2005 Gündisch D. Nicotinic acetylcholine receptor ligands as potential therapeutics Expert Opinion On Therapeutic Patents. 15: 1221-1239. DOI: 10.1517/13543776.15.9.1221  0.433
2004 Zlotos DP, Gündisch D, Ferraro S, Tilotta MC, Stiefl N, Baumann K. Bisquaternary caracurine V and iso-caracurine V salts as ligands for the muscle type of nicotinic acetylcholine receptors: SAR and QSAR studies. Bioorganic & Medicinal Chemistry. 12: 6277-85. PMID 15519170 DOI: 10.1016/j.bmc.2004.08.053  0.485
2004 Peters L, Wright AD, Kehraus S, Gündisch D, Tilotta MC, König GM. Prenylated indole alkaloids from Flustra foliacea with subtype specific binding on NAChRs. Planta Medica. 70: 883-6. PMID 15490312 DOI: 10.1055/s-2004-832610  0.339
2004 Schmaljohann J, Minnerop M, Karwath P, Gündisch D, Falkai P, Guhlke S, Wüllner U. Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 61: 1235-40. PMID 15388115 DOI: 10.1016/j.apradiso.2004.02.026  0.414
2004 Gündisch D, Andrä M, Munoz L, Cristina Tilotta M. Synthesis and evaluation of phenylcarbamate derivatives as ligands for nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry. 12: 4953-62. PMID 15336274 DOI: 10.1016/j.bmc.2004.06.041  0.537
2004 Seifert S, Stehl A, Tilotta MC, Gündisch D, Seitz G. Novel enantiopure ferrugininoids active as nicotinic agents: synthesis and radioligand binding studies. Die Pharmazie. 59: 427-34. PMID 15248455  0.354
2003 Seifert S, Gündisch D, Tilotta MC, Seitz G. Improved synthesis and in vitro evaluation of quinuclidin-2-ene based ligands for the nicotinic acetylcholine receptor. Die Pharmazie. 58: 353-4. PMID 12779056  0.439
2003 Schwarz S, Kämpchen T, Tilotta MC, Gündisch D, Seitz G. Synthesis and nicotinic binding studies on enantiopure pinnamine variants with an 8-azabicyclo[3.2.1]octane moiety. Die Pharmazie. 58: 295-9. PMID 12779043  0.372
2003 Gohlke H, Schwarz S, Gündisch D, Tilotta MC, Weber A, Wegge T, Seitz G. 3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor. Journal of Medicinal Chemistry. 46: 2031-48. PMID 12747776 DOI: 10.1021/jm020859m  0.412
2002 Gohlke H, Gündisch D, Schwarz S, Seitz G, Tilotta MC, Wegge T. Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165. Journal of Medicinal Chemistry. 45: 1064-72. PMID 11855986 DOI: 10.1021/jm010936y  0.462
2002 Gündisch D, Kämpchen T, Schwarz S, Seitz G, Siegl J, Wegge T. Syntheses and evaluation of pyridazine and pyrimidine containing bioisosteres of (+/-)-pyrido[3.4-b]homotropane and pyrido-[3.4-b]tropane as novel nAChR ligands. Bioorganic & Medicinal Chemistry. 10: 1-9. PMID 11738601 DOI: 10.1016/S0968-0896(01)00258-9  0.419
2001 Gündisch D, Harms K, Schwarz S, Seitz G, Stubbs MT, Wegge T. Synthesis and evaluation of diazine containing bioisosteres of (-)-ferruginine as ligands for nicotinic acetylcholine receptors. Bioorganic & Medicinal Chemistry. 9: 2683-91. PMID 11557356 DOI: 10.1016/S0968-0896(01)00188-2  0.47
2001 Imming P, Klaperski P, Stubbs MT, Seitz G, Gündisch D. Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands. European Journal of Medicinal Chemistry. 36: 375-88. PMID 11461763 DOI: 10.1016/S0223-5234(01)01222-3  0.34
2000 Horti AG, Chefer SI, Mukhin AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, London ED. 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. Life Sciences. 67: 463-9. PMID 11003056 DOI: 10.1016/S0024-3205(00)00635-4  0.445
2000 Harms A, Gündisch D, Müller CE, Kovar KA. Development of a 5-hydroxytryptamine(2A) receptor binding assay for high throughput screening using 96-well microfilter plates. Journal of Biomolecular Screening. 5: 269-78. PMID 10992048 DOI: 10.1177/108705710000500410  0.337
2000 Gündisch D. Nicotinic acetylcholine receptors and imaging. Current Pharmaceutical Design. 6: 1143-57. PMID 10903387 DOI: 10.2174/1381612003399879  0.485
2000 Mukhin AG, Gündisch D, Horti AG, Koren AO, Tamagnan G, Kimes AS, Chambers J, Vaupel DB, King SL, Picciotto MR, Innis RB, London ED. 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Molecular Pharmacology. 57: 642-9. PMID 10692507 DOI: 10.1124/MOL.57.3.642  0.504
2000 Koren AO, Horti AG, Mukhin AG, Gündisch D, Dannals RF, London ED. Synthesis and initial in vitro characterization of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)puridine, a high-affinity radioligand for central nicotinic acetylcholine receptors Journal of Labelled Compounds and Radiopharmaceuticals. 43: 413-423. DOI: 10.1002/(SICI)1099-1344(200004)43:5<413::AID-JLCR326>3.0.CO;2-1  0.526
1999 Chefer SI, Horti AG, Koren AO, Gündisch D, Links JM, Kurian V, Dannals RF, Mukhin AG, London ED. 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. Neuroreport. 10: 2715-21. PMID 10511429 DOI: 10.1097/00001756-199909090-00005  0.47
1999 Koren AO, Horti AG, Mukhin AG, Gundisch D, Dannals RF, London ED. Synthesis and in vitro charactertzation of 6-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine, a high-affinity radioligand for central nicotinic acetylcholine receptors Journal of Labelled Compounds and Radiopharmaceuticals. 42: S409-S410.  0.479
1998 Koren AO, Horti AG, Mukhin AG, Gündisch D, Kimes AS, Dannals RF, London ED. 2-, 5-, and 6-Halo-3-(2(S)-azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors, and molecular modeling. Journal of Medicinal Chemistry. 41: 3690-8. PMID 9733494 DOI: 10.1021/jm980170a  0.528
Show low-probability matches.